Trials / Unknown
UnknownNCT05311605
REperfusion Therapy for Acute Ischemic STrOke Due to Large aRtEry Occlusion
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,600 (estimated)
- Sponsor
- Beijing Tiantan Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
The aim of the study was to establish a clinical and advanced imaging database of acute ischemic stroke patients treated with mechanical thrombectomy due to large vessel occlusion of anterior circulation within 24 hours from stroke onset in China, and to investigate the predictors and potential mechanisms of futile recanalization after mechanical thrombectomy.
Detailed description
The time-window of mechanical thrombectomy for ischemic stroke has extended from 4.5 hours to 24 hours based on the results of the DAWN and DEFUSE 3 trials. However, evidence on the effectiveness and safety of mechanical thrombectomy within 24 hours in the real-world is insufficient. This is a multi-center, prospective, registry cohort study that acute ischemic stroke patients treated with mechanical thrombectomy due to large vessel occlusion of anterior circulation within 24 hours from stroke onset in China. A retrospective dataset was also build in these stroke centers for analysis. A total of 1600 patients with advanced imaging data were anticipated to be enrolled.
Conditions
Timeline
- Start date
- 2023-02-23
- Primary completion
- 2024-09-30
- Completion
- 2024-12-31
- First posted
- 2022-04-05
- Last updated
- 2024-03-21
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05311605. Inclusion in this directory is not an endorsement.